Unlock instant, AI-driven research and patent intelligence for your innovation.

PAMAM-Rapa-BODIPY system and production method and application thereof

A systematic and natural number technology, applied in the field of diabetic eye inflammation treatment, can solve the problems of untraceable dynamic changes of rapamycin and lack of molecular probe function, so as to increase the drug tracer function and inhibit diabetic retinopathy. , the effect of reducing toxicity

Pending Publication Date: 2020-06-09
THE SECOND XIANGYA HOSPITAL OF CENT SOUTH UNIV
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These drug delivery systems do not have the function of molecular probes, and cannot track the dynamic changes of rapamycin in cells and animals

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • PAMAM-Rapa-BODIPY system and production method and application thereof
  • PAMAM-Rapa-BODIPY system and production method and application thereof
  • PAMAM-Rapa-BODIPY system and production method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0044] The present application also provides the preparation method of the above-mentioned PAMAM-Rapa-BODIPY system, comprising the following steps:

[0045] The reaction of rapamycin, bodipyrrole, polyamide-amine dendrimers and OEG in an activator and a solvent yields a PAMAM-Rapa-BODIPY system.

[0046] In the process of preparing PAMAM-Rapa-BODIPY system, PAMAM, Rapa, BODIPY and OEG had nucleophilic addition reaction, thus the PAMAM-Rapa-BODIPY system was obtained. In the above preparation process, the activator is N-hydroxysuccinimide; the solvent is an organic solvent well known to those skilled in the art, and this application is not particularly limited. In this application, the The solvent is methanol. In order to make the reaction more fully, the preparation method of the PAMAM-Rapa-BODIPY system is specifically:

[0047] Dissolve rapamycin, boron dipyrrole and activator in an organic solvent, then activate in 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochlori...

Embodiment 1

[0052] Example 1 Preparation process of PAMAM-Rapa-BODIPY nano drug delivery system

[0053] Synthetic method: Dissolve rapamycin (Rapa), N-hydroxysuccinimide, and fluorobodipyrrole (BODIPY) in methanol solution, triethylene glycol molecule (OEG), add EDC·HCl in advance Activation and stirring for 1 h; then add polyamide-amine dendrimer (PAMAM) methanol / water mixed solution, PAMAM: N-hydroxysuccinimide: OEG: BODIPY: rapamycin molar ratio is 1:30 : 30: 1: 1; After three days of magnetic stirring at room temperature, place it in a dialysis bag and dialyze for two days; during the dialysis process, the deionized water needs to be replaced every two hours, and the water is removed by freeze-drying to obtain the product PAMAM-Rapa-BODIPY.

[0054] 1 H NMR nuclear magnetic analysis: Weigh 5 mg of PAMAM and PAMAM-Rapa-BODIPY samples with a precision balance, dissolve them in 0.5 mL of heavy water, and measure their characteristic groups with a nuclear magnetic resonance spectrometer...

Embodiment 2

[0055] Example 2 Safety and effectiveness evaluation of PAMAM-Rapa-BODIPY in cell model

[0056] 1) Cell source: human retinal pigment epithelial cell line (ARPE-19);

[0057] 2) Determination of the activity of human retinal pigment epithelial cells (CCK-8 method): collect ARPE-19 growing in the logarithmic phase, adjust the cell suspension to an appropriate concentration with DMEM-F12 containing 10% FBS, and inoculate 5000 cells in a 96-well plate after counting Each well, placed in an incubator to continue culturing overnight; 96 wells were added with different concentrations of PAMAM-Rapa (0, 10 -6 、10 -4 、10 -2 、10 -1 , 1, 10, 100, and 500 μM), the control group was sterile double-distilled water as a drug vehicle, and a zero-adjustment well was set at the same time. There were 3 duplicate wells in each group, and the culture continued for 24 hours; 1 hour before the end of the incubation, all the wells were aspirated. Add 110 μL of complete medium suspension containi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a PAMAM-Rapa-BODIPY system shown in a formula (I) as shown in the description. According to the PAMAM-Rapa-BODIPY system shown in the formula (I) as shown in the description, Mis regarded as a carrier, R2 is regarded as a fluorescent molecular indicating group, R3 is regarded as an active medicine component, and R1 makes the system soluble in water. Therefore, the providedPAMAM-Rapa-BODIPY system can mainly applied to diabetic retinopathy, and targets a microglial cell of a retina for release, and not only does the provided PAMAM-Rapa-BODIPY system play a role in anti-inflammation, but also the pharmacokinetic characteristics of a medicine in an eye an be monitored, so that the provided PAMAM-Rapa-BODIPY system has important academic value in treatment of diabeticeye inflammation.

Description

technical field [0001] The invention relates to the technical field of diabetic eye inflammation treatment, in particular to a PAMAM-Rapa-BODIPY system, its preparation method and application. Background technique [0002] Diabetic retinopathy is a type of microvascular complication of diabetes in the eye. It is the first cause of blindness among people aged 20 to 74 in western countries. Its prevention and treatment is facing a huge challenge. Retinal vascular leakage, inflammation and neovascularization are the basic pathological features of diabetic retinopathy. Intraocular injection of anti-VEGF drugs can effectively inhibit diabetic neovascularization and vascular leakage, but for early diabetic retinopathy, there is no effective local ocular method except controlling blood pressure and blood sugar and oral administration of calcium oxybenzenesulfonate to improve microcirculation. [0003] Rapamycin was originally discovered in Streptomyces and has been successfully us...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/59A61K47/54A61K9/00A61K9/19A61P3/10A61P9/10A61P27/02A61K49/00
CPCA61K47/595A61K47/54A61K9/0019A61K9/0048A61K9/19A61P3/10A61P9/10A61P27/02A61K49/0021A61K49/0054A61K49/0052
Inventor 高玲旷桂超周艳丹
Owner THE SECOND XIANGYA HOSPITAL OF CENT SOUTH UNIV